Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
20.60
+0.60 (3.00%)
At close: Oct 15, 2026, 4:00 PM EDT
20.19
-0.41 (-1.99%)
After-hours: Oct 15, 2026, 5:29 PM EDT
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $532.31 million as of October 15, 2026. It is the 14,191st most valuable company in the world and the 2,695th biggest in the United States. Its market cap has increased by 3,213.61% in one year.
Market Cap
532.31M
Enterprise Value
346.46M
1-Year Change
3,213.61%
Global Rank
Country Rank
#2,695 United States
Category
ChartMarket Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has decreased from $558.65M to $532.31M, a decrease of -4.71%. That is a compound annual growth rate of -0.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 532.31M | 3,855.37% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 540.68M |
| Crescent Biopharma | 538.44M |
| Sagimet Biosciences | 535.01M |
| Shattuck Labs | 534.94M |
| Valneva SE | 534.92M |
| Puma Biotechnology | 526.52M |
| DBV Technologies | 525.61M |
| Aclaris Therapeutics | 497.53M |